Company

mondoBIOTECH holding AG (SIX: RARE) announces today that the Board of Directors has unanimously appointed Mr. Robert Edward Patterson as Chairman and Prof. Michael Alan Keller as Vice-Chairman. Mr. Robert Edward Patterson and Prof. Michael Alan Keller have also been appointed as members of the Audit Committee and the Nomination and Compensation Committee.

mondoBIOTECH holding AG (SIX: RARE) announces that at today's Annual General Meeting, the shareholders have approved all agenda items as proposed by the Board of Directors with large majority of the represented votes. The agenda covered the approval of the annual report and the group financial statements 2011, the carrying forward of the loss generated in the year 2011, the granting of discharge to the members of the Board of Directors and the Group Executive Committee members for their tenures in the business year 2011, re-elections of all directors nominated by the Board of Directors who stood for re-election to the same and the re-election of PricewaterhouseCoopers as statutory auditors. At today’s Annual General Meeting, 61.5 % of the existing shares were represented.

mondoBIOTECH holding AG (SIX: RARE) announces that Prince Michael von und zu Liechtenstein and Graf Francis von Seilern-Anspang, both members of the Board of Directors (the “Board”) of mondoBIOTECH holding AG (the “Company”), today informed the Board that, other than announced in the invitation to the Company's ordinary shareholders meeting published by press release of 5th April 2012, they will not stand for re-election to the Board at the Company's ordinary shareholders meeting of 3rd May 2012.

mondoBIOTECH Holding AG (SIX: RARE) (“MondoBiotech”) announces today that Pierrel S.p.A. (“Pierrel”) and MondoBiotech have agreed to stop their discussions on and not to further pursue the idea of a business combination of the Contract Research Organization (CRO) of Pierrel with MondoBiotech, as expressed in the Letter of Intent signed on March 1st, 2012.

mondoBIOTECH holding AG (SIX: RARE) (the "Company") announces today that its 5th ordinary shareholders' meeting will be held on 3 May 2012 at 11.00 a.m. (CET) at the Company's headquarters at Mürgstrasse 18, in 6370 Stans, Switzerland.

The invitation to the ordinary shareholders' meeting is available on the Company's website under http://www.mondobiotech.com/investor/shareholders-meeting.